COVID-19 Update - This is to inform you that the Government of India has announced a complete lockdown in India 22nd March 2020 to 3rd May 2020. As a result, our offices will now be closed till 3rd May 2020 and all our employees will be working from home. Office telephones will not be answered, and therefore you are requested to direct all your queries related to manuscript submission, review process, publication etc. at below mentioned details.,, Mob. 8826373757, 8826859373, 9910947804

Print ISSN:-2581-4710

Online ISSN:-2581-4729


Current Issue

Year 2020

Volume: 6 , Issue: 1

Article Access statistics

Viewed: 138

Emailed: 0

PDF Downloaded: 95

IP Indian Journal of Clinical and Experimental Dermatology

Autologous serum therapy in chronic urticaria

Full Text PDF Share on Facebook Share on Twitter

Research Article

Author Details : Surendran K A K*, Nanjundaswamy B L, Sathish S, Bangaru H, Shruthi Kudari

Volume : 5, Issue : 4, Year : 2019

Article Page : 275-279

Suggest article by email


Context: Chronic urticaria is one of the most challenging and frustrating therapeutic problem faced by a
dermatologist. The simplest screening method to identify chronic autoimmune urticaria was found to be
the autologous serum skin test (ASST). Autologous serum therapy (AST) is helpful in chronic urticaria.
Aims: To evaluate the efficacy of autologous serum therapy (AST) in patients with chronic urticaria.
Settings and Design: Prospective study at a tertiary care centre.
Materials and Methods: The study group included 30 adult patients presenting with chronic urticaria. Six
separate parameters of disease activity and severity were recorded according to Urticaria Total Severity
Score (UTSS) at baseline (0 week) and at the end of treatment (9 weeks). Nine doses of Autologous
serum were given intramuscularly at an interval of 1 week. Results were assessed based on the percentage
decrease in the UTSS.
Statistical analysis used: Wilcoxon Signed rank test.
Results: Among 30 patients, ASST was positive in 15 patients (50%) and negative in 15 patients (50%). 11
patients (36%) had 31-60% response, 7 patients (23%) had 61-90% response, 4 patients (13%) had 10-30%
response and 8 patients (26%) had no response.
Among 15 ASST positive patients, 8 patients (53%) had 31-60% response, 3(20%) patients had 61-90%
whereas among 15 ASST negative patients only 3 (20%) patients had 31-60% response and 4(26.67%)
patients had 61-90%.
Conclusions: AST was found to be effective in the treatment of chronic urticaria. There was statistically
significant response both in ASST positive and negative patients.
Key Messages: Autologous serum injection therapy still remains as a cheap, effective and potentially
curative therapeutic modality even today in chronic urticaria.

Keywords: Autologous serum therapy, Urticaria, Autologous serum skin test

Doi : 10.18231/j.ijced.2019.059

How to cite : Surendran K A K, Nanjundaswamy B L, Sathish S, Bangaru H, Kudari S, Autologous serum therapy in chronic urticaria. IP Indian J Clin Exp Dermatol 2019;5(4):275-279

Copyright © 2019 by author(s) and IP Indian J Clin Exp Dermatol. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (CC-BY-NC 4.0) (